Tissue Source Site for Tumor Analysis

The National Institutes of Health National Cancer Institute awarded this Master IDIQ on December 30, 2015, to procure tissue and biospecimen acquisition services for the Clinical Proteomic Tumor Analysis Consortium (CPTAC), with a shared ceiling of $6.5 million and ordering authority that closed on March 22, 2021. Ordering is no longer open; the vehicle reached its cutoff date more than five years ago.

The vehicle has completed its ordering lifecycle. Twenty-one task orders were placed across four years of activity, with peak ordering in 2016 and 2018. Combined potential value across all task orders is $1.9 million, fully obligated. The most recent order was placed on July 15, 2019.

Work centers on acquisition of human tissue samples and associated medical imaging to support proteomic tumor analysis. Task orders price tissue cases at per-unit rates (ranging from roughly $250 to $2,700 per case, with imaging typically at $250 per case) and request medical images for biospecimen documentation. All orders are firm fixed price.

Competition concentrated heavily in the top four primes. Miedzynarodowy Instytut Onkologii Molekularnej holds $1.1 million (58% of combined potential value) across five orders. Biopartners, Inc. captures $673 thousand across three orders. William Beaumont Hospital and Boston Medical Center Corporation hold $122 thousand and $23 thousand respectively across eight combined orders. The remaining four primes (including University of California, San Diego and Analytical Biological Services Inc.) share less than $18 thousand. The top prime alone accounts for more than half of all awarded value.

All task orders funded the National Cancer Institute; no other federal agencies used the vehicle. Ninety-five percent of orders carried no set-aside designation; one small-business order was placed.

Individual task-order values span from zero-dollar administrative actions to $632 thousand (Biopartners' HHSN261201600012I-HHSN26100001), with most substantive orders ranging between $5 thousand and $140 thousand. Task order durations typically ran 12 to 24 months from award to completion.

This vehicle is closed to new ordering and represents a completed, narrow-scope research acquisition. Pursuit is not viable.

Tissue Purchase Order Acquisitions for NCI's Clinical Proteomic Tumor Analysis Consortium (CPTAC)